Ofev®
Idiopathic Pulmonary Fibrosis
Clinical trials
3
Developer
Boehringer Ingelheim
Overview
Ofev® is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 3 tracked IPF clinical trials.
Ofev® clinical trials
Explore related
Medical disclaimer. This page summarizes research about Ofev® for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.